HIV Clinical Trial
Official title:
Tropical Medicine Center (TMC), Kaohsiung Medicine University Hospital (KMUH)
| Verified date | January 2017 |
| Source | Kaohsiung Medical University Chung-Ho Memorial Hospital |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
1. Written informed consent must be obtained before any study specific procedures are
undertaken.
2. The process of the experiment (brief describe) The patients must come back for follow
during 4 to 12 weeks after starting the new therapy. The investigators will follow the
patients' lipid profile and any side effects and stop the observation till 36 months
after starting the new therapy. The serum level of HIV-VL, CD4, GOT, GPT, triglyceride,
cholesterol, HDL-cholesterol, and LDL-cholesterol will be checked every 3 months. The
patients' chart and all data will be delinked to protect the patients' right and
privacy.
| Status | Completed |
| Enrollment | 100 |
| Est. completion date | June 27, 2017 |
| Est. primary completion date | June 27, 2017 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | N/A and older |
| Eligibility |
Inclusion Criteria: - HIV-infected patients who receive HAART therapy but have metabolic side effects. - Age over 20 years old Exclusion Criteria: - Abnormal liver function: GOT or GPT 5 times over normal upper limit |
| Country | Name | City | State |
|---|---|---|---|
| Taiwan | Tropical medicine center | Kaohsiung |
| Lead Sponsor | Collaborator |
|---|---|
| Kaohsiung Medical University Chung-Ho Memorial Hospital |
Taiwan,
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06162897 -
Case Management Dyad
|
N/A | |
| Completed |
NCT03999411 -
Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients
|
Phase 4 | |
| Completed |
NCT02528773 -
Efficacy of ART to Interrupt HIV Transmission Networks
|
||
| Active, not recruiting |
NCT05454839 -
Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in South Africa
|
||
| Recruiting |
NCT05322629 -
Stepped Care to Optimize PrEP Effectiveness in Pregnant and Postpartum Women
|
N/A | |
| Completed |
NCT02579135 -
Reducing HIV Risk Among Adolescents: Evaluating Project HEART
|
N/A | |
| Active, not recruiting |
NCT01790373 -
Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence
|
N/A | |
| Not yet recruiting |
NCT06044792 -
The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH
|
||
| Completed |
NCT04039217 -
Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM
|
Phase 4 | |
| Active, not recruiting |
NCT04519970 -
Clinical Opportunities and Management to Exploit Biktarvy as Asynchronous Connection Key (COMEBACK)
|
N/A | |
| Completed |
NCT04124536 -
Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women
|
N/A | |
| Recruiting |
NCT05599581 -
Tu'Washindi RCT: Adolescent Girls in Kenya Taking Control of Their Health
|
N/A | |
| Active, not recruiting |
NCT04588883 -
Strengthening Families Living With HIV in Kenya
|
N/A | |
| Completed |
NCT02758093 -
Speed of Processing Training in Adults With HIV
|
N/A | |
| Completed |
NCT02500446 -
Dolutegravir Impact on Residual Replication
|
Phase 4 | |
| Completed |
NCT03805451 -
Life Steps for PrEP for Youth
|
N/A | |
| Active, not recruiting |
NCT03902431 -
Translating the ABCS Into HIV Care
|
N/A | |
| Completed |
NCT00729391 -
Women-Focused HIV Prevention in the Western Cape
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05736588 -
Elimisha HPV (Human Papillomavirus)
|
N/A | |
| Recruiting |
NCT03589040 -
Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant
|
Phase 2 |